Cellastra
Pre-clinicalCellastra Inc is using a natural derivative of Lactoferrin (Ensereptide) and a novel strategy combining it with AAV Technology, Cellastra aim to target: Pulmonary Fibrosis, Burn Injuries, Aesthetic or Other Surgery
Founded
2021
Focus
RNA & Gene Therapy
About
Cellastra Inc is using a natural derivative of Lactoferrin (Ensereptide) and a novel strategy combining it with AAV Technology, Cellastra aim to target: Pulmonary Fibrosis, Burn Injuries, Aesthetic or Other Surgery
Company Info
TypePrivate
Founded2021
LocationSan Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile